WJPR Citation Report New

  All Since 2021
 Citation  9186  4781
 h-index  32  25
 i10-index  256  108

Submit Article

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

NEXT-GENERATION PHARMACEUTICAL INNOVATIONS IN MENINGOCOCCAL DISEASE: PRECISION VACCINE DELIVERY, NANOTECHNOLOGY-ENABLED THERAPEUTICS, AND ADVANCED FORMULATION ENGINEERING

D. Steven Paul, V. Sudheer, B. Mastan, Prasanna Kumar Desu, Anusha Raouri, Kasietti Ashok Babu, Yaparthi Suneetha, David Raju Busi*

Abstract

Meningococcal disease is a serious health issue worldwide. It is caused by Neisseria meningitidis which can cause meningitis and meningococcal infection, both which can be life threatening. Vaccination, antimicrobial therapy and supportive medical care have improved but the condition still causes significant morbidity and mortality due to its rapid progression, changing epidemiology, antibiotic resistance and limitations of modern vaccine methods. This review covers novel pharmaceutical technologies for the prevention, diagnosis and treatment of meningococcal disease, including precision vaccine delivery, nanotechnology-enabled therapeutics and advanced formulation engineering. Precision vaccine approaches such as genomic surveillance, antigen matching, reverse vaccinology and structural vaccinology can improve vaccine selection and broader protective immune responses. Using nanotechnology based on delivery systems such as liposomes, lipid nanoparticles, polymeric nanoparticles and nanoemulsions are being studied to improve drug delivery, enhance antigen stability, provide controlled drug release and possibly improve therapeutic targeting . In addition, sophisticated formulation approaches including microencapsulation, lyophilization, spray drying, stabilizer-assisted formulations and controlled-release systems may enhance product stability, shelf life, patient acceptability and distribution. To control diseases, it is mandatory to integrate vaccination, early detection, antimicrobial treatment and modern drug delivery technologies. Safety, toxicity, clinical efficacy, regulatory clearance, manufacturing capacity, cost and accessibility remain important challenges to consider. Future research must target the development of pharmaceutical technologies which are safe, effective, stable and cost-effective, supported by relevant preclinical and clinical investigations. Overall, these emerging innovations hold great promise for improving the prevention and management of meningococcal disease and for improving public health outcomes worldwide.

Keywords: Meningococcaldisease, Neisseria meningitidis, Precision vaccine delivery, Nanotechnology, Nanocarriers, Advanced formulation engineering, Controlled drug release, Vaccine development.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More